Clinical Precise Diagnosis and Treatment in the Kawasaki Disease
Study Details
Study Description
Brief Summary
The purpose of this project is to explore the differential gene expression profile of Kawasaki disease, and will explore the diagnosis and treatment targets related to coronary artery injury or kawasaki disease susceptibility, vascular damage, IVIG (intravenous immunoglobulin) treatment resistance, incomplete Kawasaki disease, etc.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent will acquire blood samples with complete clinical data and prognostic information. Using clinicopathology, molecular biology, gene diagnostics and other techniques to verify the expression differences of target genes and proteins and analyze their expression levels; To analyze the role of target genes and proteins in the occurrence and development of Kawasaki disease and their correlation with the risk of coronary artery injury. In vitro and in vivo KD (Kawasaki Disease) model was used to investigate the role of target genes in Kawasaki disease by gene interference and various molecular biological techniques.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Health Control Health children with age and sex paired with experimental group |
Diagnostic Test: Echocardiography, Genomics NGS sequencing
The inner diameter of left main coronary artery, anterior descending branch, circumflex branch and right coronary artery was measured by echocardiography. Blood samples were send for genomics NGS sequencing
|
Kawasaki Disease KD patients, with no congenital heart disease, metabolic disease or Immune deficiency disease. |
Diagnostic Test: Echocardiography, Genomics NGS sequencing
The inner diameter of left main coronary artery, anterior descending branch, circumflex branch and right coronary artery was measured by echocardiography. Blood samples were send for genomics NGS sequencing
|
Outcome Measures
Primary Outcome Measures
- Z-score of coronary artery [2 weeks]
Calculate z-score by using LMS regression form echocardiography data
- Z-score of coronary artery [4 weeks]
Calculate z-score by using LMS regression form echocardiography data
- Differential gene profile [0 week]
Differential expression analysis of NGS sequencing in genomics
- Differential gene profile [1 week after IVIG treatment]
Differential expression analysis of NGS sequencing in genomics
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Individual patient's medical file data confirmed the diagnosis of KD using diagnostic criteria issued by the American Heart Association in 2017;
-
Patients were respond to IVIG treatment;
-
the patients aged from 2 months to 14 years old;
-
All included patients required to sign an informed consent form.
Exclusion Criteria:
-
The patients with severe infections;
-
The patients with a history of tuberculosis or recent close contact with tuberculosis;
-
The patient vaccinated with live vaccine in 6 months;
-
The patients with the application of hormone or other immunosuppressive agents;
-
The patients didn"t want to signed informed consent.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Affiliated Hospital of Nantong University | Nantong | Jangsu | China | 226000 |
2 | Jiangsu Hailan People's Hospital | Haian | Jiangsu | China | 226000 |
3 | Nantong first People's Hospital | Nantong | Jiangsu | China | 226000 |
4 | Children's Hospital of Fudan University Qidong Branch | Qidong | Jiangsu | China | 226000 |
Sponsors and Collaborators
- Affiliated Hospital of Nantong University
- Children's Hospital of Fudan University Qidong Branch
- Second Affiliated Hospital of Nantong University
- Jiangsu Hai'an People's Hospital
Investigators
- Study Chair: Jianmei Zhao, PhD., Affiliated Hospital of Nantong University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LCYJ-A06